We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Hand-Held Image-Guided Percutaneous Access Device Precisely Targets Anatomical Structures

By HospiMedica International staff writers
Posted on 12 Jun 2023
Print article
Image: The CERTA Access System has successfully completed its first human cases (Photo courtesy of Freepik)
Image: The CERTA Access System has successfully completed its first human cases (Photo courtesy of Freepik)

Early central venous catheter (CVC) insertion has been shown to significantly decrease mortality and hospitalization rates in severely ill patients in the ICU and ER. Now, a groundbreaking handheld device that combines imaging and robotics aims to enhance the precision, safety, and reliability of accessing targeted anatomical structures. This advanced technology, designed specifically for high-volume procedures such as CVC placement, could help healthcare professionals of different training levels and experience to safely and effectively achieve vascular access.

Obvius Robotics (Weston, FL, USA) has developed CERTA Access System, an innovative technology platform for performing percutaneous access. This system integrates image guidance and accurate needle placement in a handheld device, which enables clinicians to swiftly and reliably identify target structures like blood vessels, and obtain access for procedures such as CVC placement in the subclavian and jugular veins.

Currently in the development stage, the CERTA Access System allows clinicians to target and access anatomical structures single-handedly at the push of a button, using a unique targeting system and needle assembly. While the CERTA Access System has successfully completed its first study in humans, it is not yet commercially available, as the company is in the process of seeking regulatory approval and preparing for market launch.

"CERTA enables clinicians of various levels of experience to quickly and reliably treat these patients, and in so doing, democratizes and standardizes a common procedure that today requires a certain level of skill and experience," said William Cohn, MD, Chief Medical Officer of Obvius Robotics and inventor of the CERTA Access System.

"This successful first-in-human study comes after two years of rigorous work proving the design and value proposition in a preclinical setting," added Russell Seiber, CEO and President of Obvius Robotics. "We hope this will mark an important milestone in bringing this potentially groundbreaking technology to patients on a global scale."

Related Links:
Obvius Robotics

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
Autoclave
Advance
Cardiograph Device
PageWriter TC35

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.